Hydroxyzine Orifarm (Hydroxyzine Hydrochloride)

Hydroxyzine hydrochloride works by selectively blocking peripheral H1 histamine receptors, which reduces the effects of histamine such as itching, swelling, and vasodilation. Its additional anticholinergic and serotonergic activities contribute to its anxiolytic and sedative properties, making it useful for both allergic and calming indications.

The appropriate dose of Hydroxyzine Orifarm is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Dosage regimens may differ for allergy relief, anxiety management, or procedural sedation, and should always follow the prescriber’s instructions.

Safety data for Hydroxyzine Orifarm in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit outweighs any possible risk, and the decision should be made in consultation with a qualified healthcare provider.

To order Hydroxyzine Orifarm, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Hydroxyzine Orifarm belongs to the first‑generation antihistamine class, which typically provides stronger sedation and anxiolytic effects compared with second‑generation agents that are less sedating. While it offers rapid relief of allergic symptoms, its anticholinergic profile may lead to more pronounced side effects such as dry mouth and drowsiness.

Hydroxyzine Orifarm should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and excessive heat. Keep it out of reach of children and do not use it after the expiration date printed on the label.

Hydroxyzine Orifarm is administered orally, typically as a tablet that is swallowed whole with water. The exact route (e.g., with or without food) and timing depend on the prescriber’s instructions and the therapeutic purpose, such as allergy relief or pre‑operative sedation.

Serious risks associated with Hydroxyzine Orifarm include rare but potentially life‑threatening reactions such as anaphylaxis, severe hypotension, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, rapid heartbeat, fainting, or a sudden drop in blood pressure.

Hydroxyzine Orifarm should be avoided in individuals with known hypersensitivity to hydroxyzine or any component of the formulation. Caution is advised for patients with severe cardiac conduction disorders, uncontrolled glaucoma, or those taking other strong CNS depressants. Pregnant or breastfeeding women should only use it under strict medical supervision.